Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial.

Publication Type:

Journal Article

Source:

PloS one, Volume 6, Issue 9, p.e24517 (2011)

Keywords:

2011, Center-Authored Paper, Clinical Research Division, Vaccine and Infectious Disease Division

Abstract:

In the development of HIV vaccines, improving immunogenicity while maintaining safety is critical. Route of administration can be an important factor.